HUE057904T2 - Eljárások módosított glikozilációval bíró, rekombináns glikoproteinek elõállítására - Google Patents

Eljárások módosított glikozilációval bíró, rekombináns glikoproteinek elõállítására

Info

Publication number
HUE057904T2
HUE057904T2 HUE15770138A HUE15770138A HUE057904T2 HU E057904 T2 HUE057904 T2 HU E057904T2 HU E15770138 A HUE15770138 A HU E15770138A HU E15770138 A HUE15770138 A HU E15770138A HU E057904 T2 HUE057904 T2 HU E057904T2
Authority
HU
Hungary
Prior art keywords
methods
producing recombinant
modified glycosylation
recombinant glycoproteins
glycoproteins
Prior art date
Application number
HUE15770138A
Other languages
English (en)
Inventor
Nien-Yi Chen
Che-Haorz Wu
Hung-Chi Chen
Winston Town
Original Assignee
Oneness Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oneness Biotech Co Ltd filed Critical Oneness Biotech Co Ltd
Publication of HUE057904T2 publication Critical patent/HUE057904T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01051Alpha-L-fucosidase (3.2.1.51)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
HUE15770138A 2014-03-17 2015-03-17 Eljárások módosított glikozilációval bíró, rekombináns glikoproteinek elõállítására HUE057904T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461954337P 2014-03-17 2014-03-17

Publications (1)

Publication Number Publication Date
HUE057904T2 true HUE057904T2 (hu) 2022-06-28

Family

ID=54068262

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15770138A HUE057904T2 (hu) 2014-03-17 2015-03-17 Eljárások módosított glikozilációval bíró, rekombináns glikoproteinek elõállítására

Country Status (19)

Country Link
US (2) US9540673B2 (hu)
EP (1) EP3119882B1 (hu)
JP (2) JP6701089B2 (hu)
KR (1) KR102333923B1 (hu)
CN (1) CN106715686B (hu)
AU (1) AU2015237951B2 (hu)
BR (1) BR112016021284A2 (hu)
CA (1) CA2942618A1 (hu)
DK (1) DK3119882T3 (hu)
ES (1) ES2904993T3 (hu)
HU (1) HUE057904T2 (hu)
IL (1) IL247776B (hu)
MX (1) MX2016012085A (hu)
PL (1) PL3119882T3 (hu)
PT (1) PT3119882T (hu)
RU (1) RU2704830C2 (hu)
SG (1) SG11201607759RA (hu)
TW (1) TWI682033B (hu)
WO (1) WO2015145268A2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102576850B1 (ko) * 2014-05-27 2023-09-11 아카데미아 시니카 박테로이드 기원의 푸코시다제 및 이의 사용 방법
AU2020325204B2 (en) * 2019-08-05 2024-01-04 Cho Pharma, Inc. Fusion protein for remodeling antibody glycoform
CN110885809B (zh) * 2019-12-04 2021-08-17 中国农业大学 α-L-岩藻糖苷酶及其相关生物材料与应用
AU2022289365A1 (en) 2021-06-07 2023-12-14 Amgen Inc. Using fucosidase to control afucosylation level of glycosylated proteins

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999054342A1 (en) 1998-04-20 1999-10-28 Pablo Umana Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
WO2007146847A2 (en) * 2006-06-09 2007-12-21 University Of Maryland, Baltimore Glycosylation engineered antibody therapy
CN101466402A (zh) * 2006-06-09 2009-06-24 马里兰卅大学(巴尔的摩) 糖基化改造的抗体治疗
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
EP2134834B1 (en) * 2007-03-07 2013-04-17 GlycoFi, Inc. Production of glycoproteins with modified fucosylation
KR101054362B1 (ko) * 2008-07-03 2011-08-05 재단법인 목암생명공학연구소 재조합 단백질의 푸코스 함량을 감소시키는 방법
JP2012503656A (ja) * 2008-09-26 2012-02-09 エウレカ セラピューティクス,インコーポレイテッド 変異体グリコシル化パターンを有する細胞株およびタンパク質
GB0821100D0 (en) * 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
US20120003695A1 (en) * 2009-02-25 2012-01-05 Davidson Robert C Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
US20120196310A1 (en) * 2009-10-02 2012-08-02 Christiane Jaeger A-fucosylation detection in antibodies
US10087236B2 (en) * 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
CN104220603B (zh) * 2012-02-10 2017-06-06 马里兰大学,巴尔的摩 抗体及其Fc片段的化学酶法糖基化工程

Also Published As

Publication number Publication date
IL247776A0 (en) 2016-11-30
WO2015145268A3 (en) 2016-01-21
DK3119882T3 (da) 2022-01-31
US20170145463A1 (en) 2017-05-25
ES2904993T3 (es) 2022-04-06
IL247776B (en) 2021-05-31
EP3119882A2 (en) 2017-01-25
KR20160127830A (ko) 2016-11-04
AU2015237951B2 (en) 2021-07-01
WO2015145268A2 (en) 2015-10-01
EP3119882B1 (en) 2021-11-17
WO2015145268A8 (en) 2015-12-03
US20150259720A1 (en) 2015-09-17
JP6701089B2 (ja) 2020-05-27
US9540673B2 (en) 2017-01-10
JP2020072667A (ja) 2020-05-14
RU2016140528A (ru) 2018-04-17
JP2017507664A (ja) 2017-03-23
PT3119882T (pt) 2022-01-20
CA2942618A1 (en) 2015-10-01
KR102333923B1 (ko) 2021-12-02
CN106715686B (zh) 2021-03-16
RU2704830C2 (ru) 2019-10-31
TW201623620A (zh) 2016-07-01
AU2015237951A1 (en) 2016-10-20
PL3119882T3 (pl) 2022-05-16
CN106715686A (zh) 2017-05-24
RU2016140528A3 (hu) 2018-10-18
EP3119882A4 (en) 2017-08-16
MX2016012085A (es) 2017-05-23
BR112016021284A2 (pt) 2017-10-03
TWI682033B (zh) 2020-01-11
SG11201607759RA (en) 2016-10-28
US10745729B2 (en) 2020-08-18

Similar Documents

Publication Publication Date Title
HK1246341A1 (zh) 採用重組李斯特氏菌株的聯合治療
HK1221963A1 (zh) 多肽異源多聚體的製備方法
SG10202004516VA (en) Recombinant zika vaccines
HK1218410A1 (zh) 旋翼升力航空器
GB201508138D0 (en) Aircraft
GB201416842D0 (en) Aircraft
PL3177817T3 (pl) Statek powietrzny
GB201616518D0 (en) Aircraft
HK1223980A1 (zh) 改進的重組多肽生產方法
GB201515955D0 (en) Lay-up head
HK1220492A1 (zh) 重組多肽生產
IL247776A0 (en) Methods for the production of substituted glycoproteins with adapted glycosylation
IL258981A (en) Methods for the production of proteins
PL3469071T3 (pl) Herpewirus ze zmodyfikowaną glikoproteiną D
HUE037206T2 (hu) Autokláv
HK1258962A1 (zh) 改進的重組產生方法
GB201515185D0 (en) Glycosylation process
GB201415183D0 (en) Glycosylation process
GB201407115D0 (en) Glycoproteins
TWD174410S (zh) 上機箱
ZA201500260B (en) Aircraft
GB201315265D0 (en) Glycosylation process
TWM488872U (en) Structure improvement for oven
GB201309068D0 (en) Glycosylation method
GB201301023D0 (en) Glycosylation method